UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 489

Sortiert nach

In Vitro Antifungal Susceptibility Testing of Candida Isolates with the EUCAST Methodology, a New Method for ECOFF Determination

Antimicrobial agents and chemotherapy, 2017-04, Vol.61 (4)

2017

Link zum Volltext

Verfügbarkeit prüfen

A Novel Y319H Substitution in CYP51C Associated with Azole Resistance in Aspergillus flavus

Antimicrobial agents and chemotherapy, 2015-10, Vol.59 (10), p.6615-6619

2015

Link zum Volltext

Verfügbarkeit prüfen

EUCAST expert rules in antimicrobial susceptibility testing

Clinical microbiology and infection, 2013-02, Vol.19 (2), p.141-160

2013

Link zum Volltext

Verfügbarkeit prüfen

Exposure to Ceftobiprole Is Associated with Microbiological Eradication and Clinical Cure in Patients with Nosocomial Pneumonia

Antimicrobial agents and chemotherapy, 2014-05, Vol.58 (5), p.2512-2519

2014

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and Pharmacodynamics of Murepavadin in Neutropenic Mouse Models

Antimicrobial agents and chemotherapy, 2019-03, Vol.63 (3)

2019

Link zum Volltext

Verfügbarkeit prüfen

The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach

Clinical microbiology and infection, 2012-03, Vol.18 (3), p.E37-E45

2012

Link zum Volltext

Verfügbarkeit prüfen

Amplification of Antimicrobial Resistance in Gut Flora of Patients Treated with Ceftriaxone

Antimicrobial agents and chemotherapy, 2017-11, Vol.61 (11)

2017

Link zum Volltext

Verfügbarkeit prüfen

How to: EUCAST recommendations on the screening procedure E.Def 10.1 for the detection of azole resistance in Aspergillus fumigatus isolates using four-well azole-containing agar plates

Clinical microbiology and infection, 2019-06, Vol.25 (6), p.681-687

2019

Link zum Volltext

Verfügbarkeit prüfen

Epidemiological Cutoff Values for Azoles and Aspergillus fumigatus Based on a Novel Mathematical Approach Incorporating cyp51A Sequence Analysis

Antimicrobial Agents and Chemotherapy, 2012-05, Vol.56 (5), p.2524-2529

2012

Link zum Volltext

Verfügbarkeit prüfen

Intra- and Interlaboratory Agreement in Assessing the In Vitro Activity of Micafungin against Common and Rare Candida Species with the EUCAST, CLSI, and Etest Methods

Antimicrobial agents and chemotherapy, 2016-10, Vol.60 (10), p.6173-6178

2016

Link zum Volltext

Verfügbarkeit prüfen

Antifungal Susceptibility Patterns of Opportunistic Fungi in the Genera Verruconis and Ochroconis

Antimicrobial agents and chemotherapy, 2014-06, Vol.58 (6), p.3285-3292

2014

Link zum Volltext

Verfügbarkeit prüfen

Erratum for Meletiadis et al., "Amplification of Antimicrobial Resistance in Gut Flora of Patients Treated with Ceftriaxone"

Antimicrobial agents and chemotherapy, 2018-12, Vol.62 (12)

2018

Link zum Volltext

Verfügbarkeit prüfen

The development and implementation of a guideline-based clinical decision support system to improve empirical antibiotic prescribing

BMC medical informatics and decision making, 2022-05, Vol.22 (1), p.127-127, Article 127

2022

Link zum Volltext

Verfügbarkeit prüfen

Oral amoxicillin and amoxicillin–clavulanic acid: properties, indications and usage

Clinical microbiology and infection, 2020-07, Vol.26 (7), p.871-879

2020

Link zum Volltext

Verfügbarkeit prüfen

Plasma and epithelial lining fluid pharmacokinetics of ceftolozane and tazobactam alone and in combination in mice

Antimicrobial agents and chemotherapy, 2015-06, Vol.59 (6), p.3373-3376

2015

Link zum Volltext

Verfügbarkeit prüfen

Susceptibility Breakpoints for Amphotericin B and Aspergillus Species in an In Vitro Pharmacokinetic-Pharmacodynamic Model Simulating Free-Drug Concentrations in Human Serum

Antimicrobial agents and chemotherapy, 2014-04, Vol.58 (4), p.2356-2362

2014

Link zum Volltext

Verfügbarkeit prüfen

Decreased ciprofloxacin susceptibility in Salmonella Typhi and Paratyphi infections in ill-returned travellers: the impact on clinical outcome and future treatment options

European journal of clinical microbiology & infectious diseases, 2013-10, Vol.32 (10), p.1295-1301

2013

Link zum Volltext

Verfügbarkeit prüfen

Effect of Manganese in Test Media on In Vitro Susceptibility of Enterobacteriaceae and Acinetobacter baumannii to Tigecycline

Journal of Clinical Microbiology, 2012-09, Vol.50 (9), p.3077-3079

2012

Link zum Volltext

Verfügbarkeit prüfen

Comparison of NCCLS and 3-(4,5-Dimethyl-2-Thiazyl)-2,5-Diphenyl-2H-Tetrazolium Bromide (MTT) Methods of In Vitro Susceptibility Testing of Filamentous Fungi and Development of a New Simplified Method

Journal of Clinical Microbiology, 2000-08, Vol.38 (8), p.2949-2954

2000

Link zum Volltext

Verfügbarkeit prüfen

Long Journey from Minimum Inhibitory Concentration Testing to Clinically Predictive Breakpoints: Deterministic and Probabilistic Approaches in Deriving Breakpoints

Infection, 2009-08, Vol.37 (4), p.296-305

2009

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of Itraconazole and Hydroxyitraconazole in Healthy Subjects after Single and Multiple Doses of a Novel Formulation

Antimicrobial Agents and Chemotherapy, 2006-12, Vol.50 (12), p.4096-4102

2006

Link zum Volltext

Verfügbarkeit prüfen

European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical Notes on antimicrobial susceptibility testing

Clinical microbiology and infection, 2006-06, Vol.12 (6), p.501-503

2006

Link zum Volltext

Verfügbarkeit prüfen

EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents

Clinical microbiology and infection, 2016-06, Vol.22 (6), p.571.e1-571.e4

2016

Link zum Volltext

Verfügbarkeit prüfen

Identification of Pseudomonas aeruginosa and Aspergillus fumigatus mono- and co-cultures based on volatile biomarker combinations

Journal of breath research, 2016-01, Vol.10 (1), p.016002-016002

2016

Link zum Volltext

Verfügbarkeit prüfen

Use of old antibiotics now and in the future from a pharmacokinetic/pharmacodynamic perspective

Clinical microbiology and infection, 2015-10, Vol.21 (10), p.881-885

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 489

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(434)
Mit Volltextzugriff
(456)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(364)
Life Sciences & Biomedicine
(326)
Humans
(228)
Microbiology
(191)
Biological And Medical Sciences
(170)
Medical Sciences
(152)
Pharmacology & Pharmacy
(150)
Infectious Diseases
(143)
Female
(108)
Pharmacology. Drug Treatments
(106)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(97)
Male
(97)
Microbial Sensitivity Tests
(96)
Animals
(83)
Adult
(69)
Antibacterial Agents
(51)
Anti-Bacterial Agents - Pharmacology
(46)
Anti-Bacterial Agents - Pharmacokinetics
(45)
Middle Aged
(45)
Antifungal Agents
(40)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(13)

Menü

Weitere Dienste

Einstellungen

In Vitro Antifungal Susceptibility Testing of Candida Isolates with the EUCAST Methodology, a New Method for ECOFF Determination

A Novel Y319H Substitution in CYP51C Associated with Azole Resistance in Aspergillus flavus

EUCAST expert rules in antimicrobial susceptibility testing

Exposure to Ceftobiprole Is Associated with Microbiological Eradication and Clinical Cure in Patients with Nosocomial Pneumonia

Pharmacokinetics and Pharmacodynamics of Murepavadin in Neutropenic Mouse Models

The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach

Amplification of Antimicrobial Resistance in Gut Flora of Patients Treated with Ceftriaxone

How to: EUCAST recommendations on the screening procedure E.Def 10.1 for the detection of azole resistance in Aspergillus fumigatus isolates using four-well azole-containing agar plates

Epidemiological Cutoff Values for Azoles and Aspergillus fumigatus Based on a Novel Mathematical Approach Incorporating cyp51A Sequence Analysis

Intra- and Interlaboratory Agreement in Assessing the In Vitro Activity of Micafungin against Common and Rare Candida Species with the EUCAST, CLSI, and Etest Methods

Antifungal Susceptibility Patterns of Opportunistic Fungi in the Genera Verruconis and Ochroconis

Erratum for Meletiadis et al., "Amplification of Antimicrobial Resistance in Gut Flora of Patients Treated with Ceftriaxone"

The development and implementation of a guideline-based clinical decision support system to improve empirical antibiotic prescribing

Oral amoxicillin and amoxicillin–clavulanic acid: properties, indications and usage

Plasma and epithelial lining fluid pharmacokinetics of ceftolozane and tazobactam alone and in combination in mice

Susceptibility Breakpoints for Amphotericin B and Aspergillus Species in an In Vitro Pharmacokinetic-Pharmacodynamic Model Simulating Free-Drug Concentrations in Human Serum

Decreased ciprofloxacin susceptibility in Salmonella Typhi and Paratyphi infections in ill-returned travellers: the impact on clinical outcome and future treatment options

Effect of Manganese in Test Media on In Vitro Susceptibility of Enterobacteriaceae and Acinetobacter baumannii to Tigecycline

Comparison of NCCLS and 3-(4,5-Dimethyl-2-Thiazyl)-2,5-Diphenyl-2H-Tetrazolium Bromide (MTT) Methods of In Vitro Susceptibility Testing of Filamentous Fungi and Development of a New Simplified Method

Long Journey from Minimum Inhibitory Concentration Testing to Clinically Predictive Breakpoints: Deterministic and Probabilistic Approaches in Deriving Breakpoints

Pharmacokinetics of Itraconazole and Hydroxyitraconazole in Healthy Subjects after Single and Multiple Doses of a Novel Formulation

European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical Notes on antimicrobial susceptibility testing

EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents

Identification of Pseudomonas aeruginosa and Aspergillus fumigatus mono- and co-cultures based on volatile biomarker combinations

Use of old antibiotics now and in the future from a pharmacokinetic/pharmacodynamic perspective

Suchergebnisse filtern